Wednesday, March 19, 2014

AmWatch - Genting Bhd : Gives funding to medical software developer HOLD, 19 Mar 2014

STOCK FOCUS OF THE DAY
Genting Bhd : Gives funding to medical software developer        HOLD


According to news reports, Genting Bhd has provided medical software developer CorTechs Labs, Inc with financing to support the company’s growth. According to sources on the Internet, the size of the funding was US$1.2mil.
CorTechs is the developer of a leading software solution for the quantification of volumetric brain atrophy, which can help diagnose a variety of brain disorders. The software NeuroQuant is used by hundreds of neurologists, radiologists, and clinical researchers in the world. Bloomberg reported that the funding given to CorTechs by Genting Bhd will help accelerate the development of CorTechs’ industry-changing image analysis software and expand its sales and marketing initiatives.
We are neutral on this development. The size of funding of US$1.2mil is not large. This is not Genting Bhd’s first foray into pharmaceuticals. Genting Bhd has also been investing in associate stakes in various companies in the past.
In December 2013, Genting Bhd bought an 8.4% in Linc Energy for S$57.4mil. Linc Energy has a portfolio of oil, gas and coal assets and underground coal gasification technology. In November 2012, Genting Bhd invested US$111.8mil in a 20% stake in TauRx Pharmaceuticals. In 2010, Genting Bhd acquired a 20% stake in Union Bank of Colombo, Sri Lanka for RM27mil.  
We believe that Genting Bhd’s company level cash is more than RM1bil. We reckon that the cash reserves would be used to partly finance the Banten Power Plant in Java, which will cost RM1bil. In addition, we believe that part of the cash would be allocated for the equity portion of the “Resorts World Las Vegas” project. Phase 1 of the project is estimated to cost US$2-3bil. Maintain HOLD on Genting Bhd.




NEWS HIGHLIGHTS
Property Sector : Country Garden, KPRJ plan massive reclamation development for luxury homes
Automotive Sector : Passenger, commercial vehicle sales up 12.6%
Plantation Sector : Full mandate of B5 biodiesel use soon
Plantation Sector : Malaysia increases CPO export tax







DISCLAIMER:
The information and opinions in this report were prepared by AmResearch Sdn Bhd. The investments discussed or recommended in this report may not be suitable for all investors. This report has been prepared for information purposes only and is not an offer to sell or a solicitation to buy any securities. The directors and employees of AmResearch Sdn Bhd may from time to time have a position in or with the securities mentioned herein. Members of the AmInvestment Group and their affiliates may provide services to any company and affiliates of such companies whose securities are mentioned herein. The information herein was obtained or derived from sources that we believe are reliable, but while all reasonable care has been taken to ensure that stated facts are accurate and opinions fair and reasonable, we do not represent that it is accurate or complete and it should not be relied upon as such. No liability can be accepted for any loss that may arise from the use of this report. All opinions and estimates included in this report constitute our judgement as of this date and are subject to change without notice.



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Related Posts with Thumbnails